genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
16 June 2020
Investor Presentation June 2020
View all reports >
Tuesday August 04, 2020
FTSE 100 finishes little changed as traders lack sentiment driver
Thor puts the hammer down after adding mining veteran to board
Proactive news headlines: RedX Pharma, genedrive, Futura Medical, Open Orphan
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-20 genedrive plc
Don't show this again